Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01343810
Other study ID # Pro00025227
Secondary ID 4R00AT004945-03
Status Completed
Phase N/A
First received April 25, 2011
Last updated March 6, 2014
Start date September 2010
Est. completion date October 2013

Study information

Verified date March 2014
Source Duke University
Contact n/a
Is FDA regulated No
Health authority United States: Federal GovernmentUnited States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The goal of this study is to better understand the potential value of reducing stress to ameliorate a cluster of biological and behavioral factors implicated in cardiovascular disease (CVD) risk. These factors include psychological distress, poor sleep quality, and exaggerated physiological responses to emotional stress. Results will be used to develop an innovative brief intervention to reduce risk for CVD by improving sleep quality, ameliorating psychological distress, and attenuating stress physiology.


Description:

This study will be conducted among 200 men and women participating in 8-week Mindfulness-Based Stress Reduction (MBSR) classes at Duke Integrative Medicine in Durham, North Carolina. The central hypothesis of this NIH-funded clinical trial (R00 AT004945, PI: Greeson) is that mindfulness meditation training is associated with increased levels of mindfulness and improved cognitive-emotional functioning that, together, are associated with reduced psychological distress, improved sleep quality, and less exaggerated physiological responses to emotional stress, including blood pressure and inflammation. This study is designed to examine psychological and biological mechanisms that may explain individual differences in MBSR outcomes. This knowledge is important because it will help us better understand who is most likely to benefit from mindfulness meditation training, and why. The results from this study are expected to elucidate mechanisms underlying the mental and physical health benefits of stress reduction, which can help guide clinicians in referring the most suitable patients to local MBSR programs.


Recruitment information / eligibility

Status Completed
Enrollment 87
Est. completion date October 2013
Est. primary completion date March 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

1. Willing to participate in an 8 week stress reduction training program

2. Between 18 and 65 years old

3. Generally in good health and not taking medication

4. Able to speak and read English

5. Willing to provide informed consent

6. Able to access the internet

7. Able to attend 4 study visits at Duke University Medical Center

Exclusion Criteria:

1. Younger than 18 years old/Older than 65

2. Asthma

3. Allergies

4. Arthritis

5. Autoimmune disease (Lupus)

6. Cancer

7. Cardiovascular disease, heart attack, or atherosclerosis

8. Diabetes or High Blood Sugar (>124 mg/dl)

9. Hypertension or high blood pressure (140/90 mmHg)

10. High cholesterol (>240 mg/dl)

11. Obesity (Body Mass Index >30)

12. Irritable Bowel Syndrome (IBS)

13. Mitral Valve Prolapse, or Heart Murmurs

14. Irregular Menstrual Cycles (Peri-Menopause Excluded. Menopause may be included.)

15. Skin conditions, such as eczema or psoriasis (acne may be included)

16. Sleep Apnea

17. Depression, anxiety, substance use, or any other mental health diagnosis

18. Sleep aids like Tylenol PM or Ambien on a regular basis

19. Medication for allergies or asthma on a regular basis

20. Aspirin or baby Aspirin on a regular basis

21. Oral contraceptives or birth control (women only)

22. Hormone Replacement Therapy

23. Flu shot within past 3 weeks

24. Underweight (BMI < 18.5)

25. Current smoker

26. >1 alcoholic drink/day (women)/ >2 alcoholic drinks/day (men)

27. Hospitalized within the last 3 months

28. Treated for any infections within the last 3 months

29. Current meditation practice >1x/month

30. Previously taken a Mindfulness-Based Stress Reduction (MBSR) course

31. Participation in any other research studies in the past year that involved drugs or taking blood

32. Recently donated blood. (500 cc's in last 8 wks)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention


Intervention

Behavioral:
Mindfulness Based Stress Reduction (MBSR)
The MBSR program consists of 8 weekly classes that last for 2.5 hours each and a commitment to daily meditation practice for the duration of the course. Classes include didactic instruction on mindfulness and its relationship to stress and health, guided meditation practices, and group discussion. Mindfulness meditation practices include awareness of breathing, awareness of emotions, body scan, mindful hatha yoga, mindful walking, mindful eating, mindful listening, and lovingkindness (metta). Participants are expected to practice formal meditation outside of class for 20-45 min per day, 6 days per week. In addition, participants are encouraged apply mindfulness to everyday activities like eating, communicating with others, and hobbies. Written materials and audio CDs with guided meditations and yoga are provided. The course also includes one full day (7-hours) of meditation on a Saturday following the 6th week of class.
Mindfulness-Based Stress Reduction (MBSR)
The MBSR program consists of 8 weekly classes that last for 2.5 hours each and a commitment to daily meditation practice for the duration of the course. Classes include didactic instruction on mindfulness and its relationship to stress and health, guided meditation practices, and group discussion. Mindfulness meditation practices include awareness of breathing, awareness of emotions, body scan, mindful hatha yoga, mindful walking, mindful eating, mindful listening, and lovingkindness (metta). Participants are expected to practice formal meditation outside of class for 20-45 min per day, 6 days per week. In addition, participants are encouraged apply mindfulness to everyday activities like eating, communicating with others, and hobbies. Written materials and audio CDs with guided meditations and yoga are provided. The course also includes one full day (7-hours) of meditation on a Saturday following the 6th week of class.

Locations

Country Name City State
United States Duke Integrative Medicine Durham North Carolina

Sponsors (2)

Lead Sponsor Collaborator
Duke University National Center for Complementary and Integrative Health (NCCIH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sleep quality Sleep quality will be assessed using 3 different methods: daily sleep diaries, questionnaires and actigraphy. Baseline, post-intervention (2 months), follow-up (8 months) No
Primary Stress physiology Physiological responses to mild emotional stress (5-minute Anger Recall Task) will be assessed in the laboratory before and after participating in an 8-week Mindfulness-Based Stress Reduction (MBSR) program. During the stress testing sessions, we will take measures of heart rate, blood pressure, stress hormones, metabolism, inflammation, emotions, and mindful qualities. Baseline, post-intervention (2 months), follow-up (8 months) No
Secondary Mindfulness Mindful qualities, including observing, describing, non-judging, non-reactivity, acting with awareness, mindfulness, self-kindness, and common humanity. Baseline, post-intervention (2 months), follow-up (8 months) No
Secondary Health-related quality of life Global health rating; physical functioning; fatigue; satisfaction with social role; pain intensity and pain-related interference with daily activities. Baseline, post-intervention (2 months), follow-up (8 months) No
Secondary Negative Affect Anxiety; anger; depressive symptoms. Baseline, post-intervention (2 months), follow-up (8 months) No
Secondary Cognitive functioning Cognitive abilities and concerns, including attention, concentration, memory, organization, and clarity of thinking. Baseline, post-intervention (2 months), follow-up (8 months) No
Secondary Emotion regulation Rumination; avoidance; suppression; reappraisal. Baseline, post-intervention (2 months), follow-up (8 months) No
Secondary Stress-related physical symptoms Common physical symptoms associated with stress, including muscle tension, gastrointestinal complaints, headaches, etc. Baseline, post-intervention (2 months), follow-up (8 months) No
See also
  Status Clinical Trial Phase
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Recruiting NCT04417387 - The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
Not yet recruiting NCT06211361 - Cardiac Rehabilitation Program in Patients With Cardiovascular Disease N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04514445 - The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT03273972 - INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers N/A
Completed NCT03680638 - The Effect of Antioxidants on Skin Blood Flow During Local Heating Phase 1
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Completed NCT04083872 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) Phase 1
Completed NCT04083846 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) Phase 1
Completed NCT03619148 - The Incidence of Respiratory Symptoms Associated With the Use of HFNO N/A
Completed NCT03693365 - Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
Completed NCT03466333 - Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia Phase 2
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT05132998 - Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)